Bohnsack Pharma Consulting

Executive Commercialization Partners for the German Generic Pharmaceutical Market

Leadership Profile

22 Years of Proven Growth, Strategy, and Flawless Market Execution

Led by a senior pharmaceutical General Manager and market access specialist, this consultancy delivers turnkey, direct-to-market concepts for generic pharmaceuticals in Germany. The framework bridges the gap between strategic concept and field execution, backed by a career featuring executive-level leadership:

• General Manager Germany – Tillomed Pharma GmbH / Emcure Group India
• Country Manager Germany – Cipla Germany for Cipla Pharma Ltd India
• International Business Development Manager – Riemser Pharma / Esteve Germany (Covering CEE, CIS, Latin America, Canada, and South Africa)
• National Key Account Manager Germany – Recordati Pharma
• Regional Sales Manager – Dedicated Hospital & Pharmacy Divisions
• Active Industry Memberships: PLCD (Pharma-License-Club Germany e.V.) and BPI (Federal Association of the Pharmaceutical Industry e.V.)

Core Business Pillars

1. Retail Market Specialization & Commercialization
Transforming complex multi-channel procurement processes into sustainable retail revenue streams through 20 years of dedicated sales and business development expertise.

End-to-End Tender Operations: Screening, strategic planning, and successful submission for open-house, exclusive, and semi-exclusive contracts.

• Commercial Channel Management: Directing interactions across the full German retail landscape, including sick funds, sick fund groups, retail pharmacies, pre-wholesalers, and wholesalers.
• Financial & Risk Optimization: Safeguarding commercial margins through precise clawback management, provider provisions, forecasting, and strict financial controlling.
• Pre-Launch Readiness: Conducting commercial market research and competitive intelligence to establish target launch models, market tracking, and pricing strategies.
• Launch Phase Implementation: Executing official IFA German price listings, direct sales rollouts, and initial targeted marketing campaigns.
• Post-Launch Strategy: Securing market share through continuous tender oversight, key opinion leader (KOL) contacts, contracting optimization, and 3-year predictive forecasting against price erosion.

2. Hospital Channel Excellence

Maximizing hospital market penetration and driving high-volume institutional sales for generic pharmaceuticals.

• Tender & Direct Sales Expertise: Proven success navigating complex hospital procurement structures and institutional bidding cycles.
• Stakeholder & Network Access: End-to-end management of hospital buying groups, clinical facilities, and hospital pharmacy purchasing networks.
• Commercialization & Marketing: Designing profitable contracting models, securing key opinion leader (KOL) relationships, and deploying specialized hospital marketing initiatives.
• Predictive Market Intelligence: Utilizing specialized hospital and tender data to build robust, two-year forward-looking supply, sales, and market share projections.

3. Corporate Transformation & Lifecycle Consulting

Steering expert organizational advisory alongside cross-functional pharmaceutical lifecycle management.

• Product Lifecycle Strategy: Seamless execution of pre-launch activities, high-stakes market entry, and generic product re-launches.
• Market Optimization: Ensuring sustained commercial growth through targeted post-launch management and predictive data analytics.
• Corporate Evolution: Strategic setup, restructuring, and organizational re-shaping of pharmaceutical companies for maximum market impact.